These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16179885)

  • 21. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease.
    Sanmartín M; Baz JA; Claro R; Asorey V; Durán D; Pradas G; Iñiguez A
    Am J Cardiol; 2007 Sep; 100(6):970-3. PubMed ID: 17826380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of sirolimus-eluting stents in diabetics with complex coronary lesions].
    Berenguer A; Mainar V; Bordes P; Valencia J; Gómez S
    Rev Esp Cardiol; 2006 Feb; 59(2):117-24. PubMed ID: 16540032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic endovascular disease: role of coronary artery revascularization.
    Stone KE; Chiquette E; Chilton RJ
    Am J Cardiol; 2007 Feb; 99(4A):105B-112B. PubMed ID: 17307063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
    Moussa I; Costa RA; Leon MB; Lansky AJ; Lasic Z; Cristea E; Trubelja N; Carlier SG; Mehran R; Dangas GD; Weisz G; Kreps EM; Collins M; Stone GW; Moses JW
    Am J Cardiol; 2006 May; 97(9):1317-21. PubMed ID: 16635603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractional flow reserve--the influence of the collateral circulation.
    Melikian N; Cuisset T; Hamilos M; De Bruyne B
    Int J Cardiol; 2009 Mar; 132(3):e109-10. PubMed ID: 18055036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era.
    Ashfaq S; Ghazzal Z; Douglas JS; Morris DC; Veledar E; Weintraub WS
    J Invasive Cardiol; 2006 Mar; 18(3):100-5. PubMed ID: 16598106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
    Elezi S; Dibra A; Folkerts U; Mehilli J; Heigl S; Schömig A; Kastrati A
    J Am Coll Cardiol; 2006 Jul; 48(2):262-7. PubMed ID: 16843172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
    Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.
    Canibus P; Faloia E; Piva T; Muçai A; Serenelli M; Perna GP; Boscaro M; Piva R
    Metabolism; 2008 May; 57(5):593-7. PubMed ID: 18442619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of diabetes mellitus on outcome after percutaneous transluminal coronary angioplasty.
    St Claire DA; King SB
    J Cardiovasc Risk; 1997 Apr; 4(2):112-20. PubMed ID: 9304492
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.
    Hong SJ; Kim MH; Ahn TH; Ahn YK; Bae JH; Shim WJ; Ro YM; Lim DS
    Heart; 2006 Aug; 92(8):1119-24. PubMed ID: 16449516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of unprotected left main coronary artery stenosis in the drug-eluting stent era.
    Tanigawa J; Sutaria N; Goktekin O; Di Mario C
    J Interv Cardiol; 2005 Dec; 18(6):455-65. PubMed ID: 16336426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The left main facts: faced, spun, but alas too few.
    Brinker J
    J Am Coll Cardiol; 2008 Mar; 51(9):893-8. PubMed ID: 18308156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
    Kumar R; Lee TT; Jeremias A; Ruisi CP; Sylvia B; Magallon J; Kirtane AJ; Bigelow B; Abrahamson M; Pinto DS; Ho KK; Cohen DJ; Carrozza JP; Cutlip DE
    Am J Cardiol; 2007 Oct; 100(8):1187-91. PubMed ID: 17920355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revascularization in high risk patients: diabetes mellitus.
    Cola C; Sabaté M
    Minerva Cardioangiol; 2007 Oct; 55(5):557-77. PubMed ID: 17912163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.